Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,110.00
+80.00 (1.33%)
At close: Apr 17, 2025, 3:30 PM KST

Dongwha Pharm.Co.,Ltd Revenue

In the year 2024, Dongwha Pharm.Co.,Ltd had annual revenue of 464.87B KRW with 28.74% growth. Dongwha Pharm.Co.,Ltd had revenue of 120.63B in the quarter ending December 31, 2024, with 43.20% growth.

Revenue
464.87B
Revenue Growth
+28.74%
P/S Ratio
0.37
Revenue / Employee
569.70M
Employees
816
Market Cap
171.30B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024464.87B103.77B28.74%
Dec 31, 2023361.11B20.68B6.08%
Dec 31, 2022340.43B47.41B16.18%
Dec 31, 2021293.02B20.94B7.70%
Dec 31, 2020272.08B-35.07B-11.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 3,557.30B
ALTEOGEN 102.85B
Yuhan 2,067.79B
SK Biopharmaceuticals 547.60B
HLB Co., Ltd. 68.13B
LigaChem Biosciences 125.90B
PharmaResearch 350.12B
Revenue Rankings